Sử dụng Sildenafil trong điều trị tăng áp lực động mạch phổi ở bệnh nhân suy tim trái mạn tính
Tóm tắt
Sử dụng Sildenafil trong điều trị tăng áp lực động mạch phổi ở bệnh nhân suy tim trái mạn tínhTài liệu tham khảo
1. Butler J, Chomsky DB, Wilson JR. Pulmonary hypertension and exercise intolerance in patients with heart failure. J Am Coll Cardiol. 1999; 34: 1802-1806.
2. Guazzi M, Samaja M, Arena R. Long-term use of sildenafil in the therapeutic management of heart failure. J Am Coll Cardiol. 2007 Nov 27;50(22):2136-44. Epub 2007 Nov 13.
3. Gregory D. Lewis, MD; Ravi Shah, MD. Sildenafil Improves Exercise Capacity and Quality of Life in Patients With Systolic Heart Failure and Secondary Pulmonary Hypertension. Circulation. 2007; 116: 1555-
4. erald Roul, MD, Philippe Germain, MD. Does the 6-minute walk test predict the prognosis in patients with NYHA class II or III chronic heart failure? Am Heart J 1998; 136:449-57.)
5. Guazzi M, Tumminello G, Di Marco F. The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure. J Am Coll Cardiol. 2004 Dec 21;44(12):2339-48.
6. Cvelich RG, Roberts SC, Brown JN. Phosphodiesterase type 5 inhibitors as adjunctive therapy in the management of systolic heart failure. Ann Pharmacother. 2011 Dec; 45 (12) : 1551-8.
7. Arnon Blum MD. Treating Heart Failure With Sildenafil. Congestive Heart Failure. Volume 15, Issue 4, 181-185, July/August 2009.
8. Cèsar Morcillo, Ofelia Aguado. Utility of the Minnesota Living With Heart Failure Questionnaire for Assessing Quality of Life in Heart Failure Patients. Rev Esp Cardiol. 2007; 60:1093-6.- Vol. 60 Num.10.
9. Behlouli H, Feldman DE. Identifying relative cut-off scores with neural networks for interpretation of the Minnesota Living with Heart Failure questionnaire. Conf Proc IEEE Eng Med Biol Soc. 2009;2009:6242-6.
